Givinostat hydrochloride hydrate

Givinostat hydrochloride monohydrate is the monohydrate form of givinostat hydrochloride. It is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy in patients 6 years of age and older. Among its listed roles, it functions as a angiogenesis inhibitor, an anti-inflammatory agent, an antineoplastic agent, an apoptosis inducer and an EC 3.5.1.98 (histone deacetylase) inhibitor. It includes a givinostat hydrochloride. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Givinostat and Givinostat hydrochloride monohydrate. Its PubChem CID is 9804991.

CAS No 732302-99-7
Molecular Formula C24H30ClN3O5
Molecular Weight 476.0 g/mol
Synonyms [6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate;hydrate;hydrochloride

Frequently Asked Questions